Jeffrey Stein - 15 Mar 2024 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: President & CEO, Director
Signature: /s/ Shane Ward, Attorney-in-Fact
Issuer symbol: CDTX
Transactions as of: 15 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 20 Mar 2024, 18:46:39 UTC
Previous filing: 12 Mar 2024
Next filing: 31 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CDTX	Common Stock						1,153,693	15 Mar 2024	Direct
holding	CDTX	Common Stock						331,602	15 Mar 2024	By trust
holding	CDTX	Common Stock						42,009	15 Mar 2024	By son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+1,040,000		$0.000000	1,040,000	15 Mar 2024	Common Stock	1,040,000	$0.6849	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 15, 2024.